StockData
Biomerica Inc logo

Biomerica Inc (BMRA) stock

BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3047% below fair value
$1.24−0.08 (-6.44%)

Close on Nov 17, 2026Market cap $5.68MP/E –Yield –

Biomerica profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Biomerica's profit margin for the twelve months ending Aug 31, 2026 was -115.5%. For fiscal 2026 it was -84.8%, against -93.6% the year before. The highest annual figure on record is 9.0% in fiscal 2012.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2026May 31, 2026-84.8%+8.9
FY2025May 31, 2025-93.6%+16.8
FY2024May 31, 2024-110.4%+23.3
FY2023May 31, 2023-133.7%−109.7
FY2022May 31, 2022-24.0%+79.4
FY2021May 31, 2021-103.4%−63.4
FY2020May 31, 2020-40.0%+6.0
FY2019May 31, 2019-46.0%−19.7
FY2018May 31, 2018-26.3%−10.7
FY2017May 31, 2017-15.7%+13.5
FY2016May 31, 2016-29.2%−22.5
FY2015May 31, 2015-6.7%−2.5
FY2014May 31, 2014-4.2%−12.5
FY2013May 31, 20138.3%−0.7
FY2012May 31, 20129.0%+5.8
FY2011May 31, 20113.2%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2027CQ3 2026Aug 31, 2026-97.4%−97.5
Q4 FY2026CQ2 2026May 31, 2026-130.9%+75.3
Q3 FY2026CQ1 2026Feb 28, 2026-132.9%−29.0
Q2 FY2026CQ4 2025Nov 30, 2025-109.1%−51.0
Q1 FY2026CQ3 2025Aug 31, 20250.1%+73.0
Q4 FY2025CQ2 2025May 31, 2025-206.1%−78.8
Q3 FY2025CQ1 2025Feb 28, 2025-103.9%+84.7
Q2 FY2025CQ4 2024Nov 30, 2024-58.1%+38.1
Q1 FY2025CQ3 2024Aug 31, 2024-72.8%−6.7
Q4 FY2024CQ2 2024May 31, 2024-127.3%+34.4
Q3 FY2024CQ1 2024Feb 29, 2024-188.6%−40.1
Q2 FY2024CQ4 2023Nov 30, 2023-96.2%+13.5
Q1 FY2024CQ3 2023Aug 31, 2023-66.1%+60.5
Q4 FY2023CQ2 2023May 31, 2023-161.7%−128.6
Q3 FY2023CQ1 2023Feb 28, 2023-148.5%−147.2
Q2 FY2023CQ4 2022Nov 30, 2022-109.7%−85.5
Q1 FY2023CQ3 2022Aug 31, 2022-126.6%−4.3
Q4 FY2022CQ2 2022May 31, 2022-33.2%+129.2
Q3 FY2022CQ1 2022Feb 28, 2022-1.4%+57.2
Q2 FY2022CQ4 2021Nov 30, 2021-24.2%+101.0
Q1 FY2022CQ3 2021Aug 31, 2021-122.3%+43.2
Q4 FY2021CQ2 2021May 31, 2021-162.3%−132.1
Q3 FY2021CQ1 2021Feb 28, 2021-58.5%+14.6
Q2 FY2021CQ4 2020Nov 30, 2020-125.2%−94.8
Q1 FY2021CQ3 2020Aug 31, 2020-165.4%−123.1
Q4 FY2020CQ2 2020May 31, 2020-30.3%+37.1
Q3 FY2020CQ1 2020Feb 29, 2020-73.2%−19.3
Q2 FY2020CQ4 2019Nov 30, 2019-30.4%+1.4
Q1 FY2020CQ3 2019Aug 31, 2019-42.4%−6.9
Q4 FY2019CQ2 2019May 31, 2019-67.4%−8.3
Q3 FY2019CQ1 2019Feb 28, 2019-53.8%−30.4
Q2 FY2019CQ4 2018Nov 30, 2018-31.8%−15.2
Q1 FY2019CQ3 2018Aug 31, 2018-35.5%−21.2
Q4 FY2018CQ2 2018May 31, 2018-59.1%−35.2
Q3 FY2018CQ1 2018Feb 28, 2018-23.4%−3.2
Q2 FY2018CQ4 2017Nov 30, 2017-16.6%−2.5
Q1 FY2018CQ3 2017Aug 31, 2017-14.3%–
Q4 FY2017CQ2 2017May 31, 2017-23.9%–
Q3 FY2017CQ1 2017Feb 28, 2017-20.3%–
Q2 FY2017CQ4 2016Nov 30, 2016-14.2%–

More Biomerica figures

See a number that looks wrong?